• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩中的边缘性阿尔茨海默病共病病理与认知障碍及诊断不准确有关。

Limbic Alzheimer's co-pathology in multiple system atrophy is associated with cognitive impairment and diagnostic inaccuracy.

作者信息

van Wetering Janna, Deshayes Natasja A C, Boone Joëlle, Rodrigues Fernandes Inês, Hepp Dagmar H, Berendse Henk W, Jonkman Laura E, Rozemuller Annemieke J M, van de Berg Wilma D J

机构信息

Section Clinical Neuroanatomy and Biobanking, Department of Anatomy and Neurosciences, Amsterdam UMC, Vrije University, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Amsterdam Neuroscience, Neurodegeneration Program, Amsterdam UMC, Amsterdam, The Netherlands.

出版信息

Acta Neuropathol. 2025 Sep 18;150(1):30. doi: 10.1007/s00401-025-02940-0.

DOI:10.1007/s00401-025-02940-0
PMID:40968282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12446110/
Abstract

The clinical heterogeneity of multiple system atrophy (MSA) may, along with the primary aggregation of alpha-synuclein (α-syn), partly be shaped by co-pathologies, such as amyloid-beta (Aβ), phosphorylated (p)-tau, and pTDP-43, though their relevance remains unclear. Here, we aimed to characterize the prevalence, morphology, regional patterns, and clinical relevance of co-pathologies in a well-characterized MSA autopsy cohort. Regional load (%area) and morphological characterization of α-syn (KM51), Aβ (6F/3D), p-tau (AT8), and pTDP-43 (pSer409) pathology were assessed in limbic regions of MSA (n = 70) donors from the Netherlands Brain Bank. APOE-ε4 genotyping and clinical parameters of the cohort were collected. Associations with clinical features were analyzed using ANCOVA and mixed linear models, adjusted for age and sex. Aβ, p-tau, and pTDP-43 pathology were detected in 31%, 91%, and 11% of all MSA cases, respectively, with the highest burdens in the entorhinal cortex and amygdala. Mixed MSA + AD cases had a higher age at death (75 ± 7 vs. 64 ± 7, p < 0.001), and more frequently APOE-ε4 alleles (p < 0.001) than pure MSA. Cognitive impairment (CDR scores) was associated with diffuse and compact Aβ plaques across all regions (r ≥ 0.24, p ≤ 0.015), p-tau pathology in CA1 and CA3 + 4 (r ≥ 0.32, p ≤ 0.020), and neuronal α-syn inclusions in the amygdala (r = 0.54, p < 0.001). No robust correlations were found between total α-syn burden and Aβ or p-tau. Misdiagnoses increased with co-pathology burden (Aβ: p = 0.040; p-tau: p = 0.020) and age at onset (80% in those with onset > 75 years). Our results demonstrate that limbic Aβ, p-tau, and neuronal α-syn pathologies occur in a substantial proportion of MSA donors and are independently associated with cognitive decline and diagnostic inaccuracy, particularly among those with older age at onset. By providing a systematic quantitative and morphological assessment of co-pathologies in limbic regions of MSA, our study advances beyond prior prevalence reports and highlights their direct clinical relevance. These findings highlight the need for refined diagnostic criteria and co-pathology-informed biomarker strategies for MSA.

摘要

多系统萎缩(MSA)的临床异质性,可能与α-突触核蛋白(α-syn)的原发性聚集一起,部分地由共病塑造,如淀粉样β蛋白(Aβ)、磷酸化(p)-tau蛋白和pTDP-43,尽管它们之间的相关性仍不清楚。在此,我们旨在描述一个特征明确的MSA尸检队列中共病的患病率、形态、区域模式及临床相关性。对来自荷兰脑库的70例MSA供体边缘区域的α-syn(KM51)、Aβ(6F/3D)、p-tau(AT8)和pTDP-43(pSer409)病理的区域负荷(%面积)和形态特征进行评估。收集该队列的APOE-ε4基因分型和临床参数。使用协方差分析和混合线性模型分析与临床特征的关联,并对年龄和性别进行校正。在所有MSA病例中,分别有31%、91%和11%检测到Aβ、p-tau和pTDP-43病理,在内嗅皮质和杏仁核中的负荷最高。混合性MSA+AD病例的死亡年龄更高(75±7岁 vs. 64±7岁,p<0.001),且APOE-ε4等位基因的频率比单纯MSA更高(p<0.001)。认知障碍(CDR评分)与所有区域的弥漫性和致密性Aβ斑块相关(r≥0.24,p≤0.015),与CA1和CA3+4区域的p-tau病理相关(r≥0.32,p≤0.020),以及与杏仁核中的神经元α-syn包涵体相关(r=0.54,p<0.001)。未发现总α-syn负荷与Aβ或p-tau之间有显著相关性。误诊率随共病负担增加(Aβ:p=0.040;p-tau:p=0.020)和发病年龄增加而增加(发病年龄>75岁者中误诊率为80%)。我们的结果表明,边缘区域的Aβ、p-tau和神经元α-syn病理在相当比例的MSA供体中出现,并且与认知下降和诊断不准确独立相关,特别是在发病年龄较大的患者中。通过对MSA边缘区域的共病进行系统的定量和形态学评估,我们的研究超越了先前的患病率报告,并突出了它们的直接临床相关性。这些发现凸显了为MSA制定更精细的诊断标准和基于共病的生物标志物策略的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/f20202cfab6f/401_2025_2940_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/a2949bb9b807/401_2025_2940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/af608219b820/401_2025_2940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/20f0982fe44a/401_2025_2940_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/f20202cfab6f/401_2025_2940_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/a2949bb9b807/401_2025_2940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/af608219b820/401_2025_2940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/20f0982fe44a/401_2025_2940_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab0/12446110/f20202cfab6f/401_2025_2940_Fig4_HTML.jpg

相似文献

1
Limbic Alzheimer's co-pathology in multiple system atrophy is associated with cognitive impairment and diagnostic inaccuracy.多系统萎缩中的边缘性阿尔茨海默病共病病理与认知障碍及诊断不准确有关。
Acta Neuropathol. 2025 Sep 18;150(1):30. doi: 10.1007/s00401-025-02940-0.
2
Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4.阿尔茨海默病及其合并病变:对海马体退化、认知衰退的影响以及载脂蛋白E ε4的作用
Alzheimers Dement. 2025 Jul;21(7):e70483. doi: 10.1002/alz.70483.
3
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.神经退行性疾病死后视网膜的神经病理学特征。
Acta Neuropathol. 2024 Aug 19;148(1):24. doi: 10.1007/s00401-024-02769-z.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion.与阿尔茨海默病表型及轻度认知障碍向阿尔茨海默病转化相关的不同脑脊液α-突触核蛋白聚集谱。
J Prev Alzheimers Dis. 2025 Feb;12(2):100040. doi: 10.1016/j.tjpad.2024.100040. Epub 2025 Jan 3.
6
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.载脂蛋白E4(APOE4)对可溶性和不溶性tau蛋白病理的影响主要受β-淀粉样蛋白的影响。
Brain. 2025 Jan 16. doi: 10.1093/brain/awaf016.
7
Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer's disease.血浆S100β是阿尔茨海默病病理学和认知衰退的一个预测指标。
Fluids Barriers CNS. 2025 Jan 9;22(1):4. doi: 10.1186/s12987-024-00615-8.
8
Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline.淀粉样蛋白-β而非 tau 积聚与纵向认知能力下降密切相关。
CNS Neurosci Ther. 2024 Jul;30(7):e14860. doi: 10.1111/cns.14860.
9
Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease.与遗忘型阿尔茨海默病相比,后皮质萎缩的病理特征
Neuropathol Appl Neurobiol. 2025 Apr;51(2):e70007. doi: 10.1111/nan.70007.
10
Abnormal Amyloid-β Duration, Tau, and Neurodegeneration in Cranial Images.颅脑影像中异常的β淀粉样蛋白持续时间、tau蛋白及神经退行性变
JAMA Netw Open. 2025 Sep 2;8(9):e2531093. doi: 10.1001/jamanetworkopen.2025.31093.

本文引用的文献

1
Comorbid pathologies and their impact on progressive supranuclear palsy: current view.共病病理及其对进行性核上性麻痹的影响:当前观点
J Neural Transm (Vienna). 2025 Aug 12. doi: 10.1007/s00702-025-03005-y.
2
Comorbid pathologies and their impact on multiple system atrophy: current view.共病病理及其对多系统萎缩的影响:当前观点
J Neural Transm (Vienna). 2025 Jun 16. doi: 10.1007/s00702-025-02972-6.
3
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B.在1B型遗传性运动感觉神经病(Charcot-Marie-Tooth type 1B)的蛋白毒性模型中,XBP1s的激活可减轻疾病严重程度。
Brain. 2025 Jun 3;148(6):1978-1993. doi: 10.1093/brain/awae407.
4
Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.帕金森病中神经元、星形胶质细胞和少突胶质细胞α-突触核蛋白病理的神经病理学阶段。
Acta Neuropathol Commun. 2025 Feb 11;13(1):25. doi: 10.1186/s40478-025-01944-x.
5
Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.神经元α-突触核蛋白毒性是多系统萎缩中神经退行性变的关键驱动因素。
Brain. 2025 Jul 7;148(7):2306-2319. doi: 10.1093/brain/awaf030.
6
N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's disease.N端α-突触核蛋白检测揭示了多系统萎缩症和帕金森病中新型且更多样化的聚集体形态。
Transl Neurodegener. 2024 Dec 27;13(1):67. doi: 10.1186/s40035-024-00456-3.
7
Co-pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases.合并症改变神经退行性疾病中海马体的蛋白质积累模式。
Alzheimers Dement. 2025 Jan;21(1):e14355. doi: 10.1002/alz.14355. Epub 2024 Dec 23.
8
Current Landscape of Clinical Diagnosis in Multiple System Atrophy: A 15-Year Analysis From 2008 to 2022.当前多系统萎缩症的临床诊断全景:2008 年至 2022 年的 15 年分析。
Neurology. 2024 Dec 10;103(11):e210021. doi: 10.1212/WNL.0000000000210021. Epub 2024 Nov 12.
9
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria.磁共振成像标志物对国际帕金森病和运动障碍学会多系统萎缩标准诊断性能的影响。
Mov Disord. 2024 Sep;39(9):1514-1522. doi: 10.1002/mds.29879. Epub 2024 Jun 7.
10
Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.神经炎症与路易体痴呆中的阿尔茨海默病共病病理相关。
Acta Neuropathol Commun. 2024 May 7;12(1):73. doi: 10.1186/s40478-024-01786-z.